Related references
Note: Only part of the references are listed.Identification of Naturally Processed Mumps Virus Epitopes by Mass Spectrometry: Confirmation of Multiple CD8+ T-Cell Responses in Mumps Patients
Jelle de Wit et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity
Eugene Lam et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Ongoing mumps outbreak among adolescents and young adults, Ireland, August 2018 to January 2020
Annamaria Ferenczi et al.
EUROSURVEILLANCE (2020)
Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine
Shih-Bin Su et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?
Paul L. Fidel et al.
MBIO (2020)
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study
Nicola P. Klein et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Measles, Mumps, Rubella Vaccination and Autism A Nationwide Cohort Study
Anders Hviid et al.
ANNALS OF INTERNAL MEDICINE (2019)
The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines
Abdulmohammad Pezeshki et al.
EXPERT REVIEW OF VACCINES (2019)
Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study
Eliane Matos dos Santos et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2019)
Differential durability of immune responses to measles and mumps following MMR vaccination
Richard B. Kennedy et al.
VACCINE (2019)
RNA Viruses as Tools in Gene Therapy and Vaccine Development
Kenneth Lundstrom
GENES (2019)
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection
Srivamshi Pittala et al.
MOLECULAR SYSTEMS BIOLOGY (2019)
It's not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook
Beth L. Hoffman et al.
VACCINE (2019)
Genomic signature of early T-cell response is associated with lower antibody titer threshold for sterilizing immunity
Eugenia Z. Ong et al.
ANTIVIRAL RESEARCH (2019)
The law on compulsory vaccination in Italy: an update 2 years after the introduction
Fortunato D’Ancona et al.
Eurosurveillance (2019)
Parental opinions towards the No Jab, No Pay policy in Australia
Mallory J. Trent et al.
VACCINE (2019)
Viral mumps: Increasing occurrences in the vaccinated population
Roger K. Lau et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2019)
Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s
David A. Geier et al.
BMC PEDIATRICS (2019)
Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood
Mohammed Ata Ur Rasheed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains
T. Vermeire et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
The Human CD4+ T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope
Jelle de Wit et al.
JOURNAL OF VIROLOGY (2019)
A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study
Darren W. Westphal et al.
LANCET INFECTIOUS DISEASES (2019)
Advances in mRNA Vaccines for Infectious Diseases
Cuiling Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mumps clinical diagnostic uncertainty
Fabio Magurano et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2018)
Intranasal immunization with dry powder vaccines
Tania F. Bahamondez-Canas et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Influenza vaccine failure: failure to protect or failure to understand?
Gregory A. Poland
EXPERT REVIEW OF VACCINES (2018)
Mumps infection but not childhood vaccination induces persistent polyfunctional CD8+ T-cell memory
Jelle de Wit et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Monitoring Viral Genetic Variation as a Tool To Improve Molecular Diagnostics for Mumps Virus
Meik Dilcher et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
Annette B. Vogel et al.
MOLECULAR THERAPY (2018)
Vaccine waning and mumps re-emergence in the United States
Joseph A. Lewnard et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial
Ashish Bavdekar et al.
VACCINE (2018)
Knowledge gaps persist and hinder progress in eliminating mumps
R. Ramanathan et al.
VACCINE (2018)
A report on the status of vaccination in Europe
Shazia Sheikh et al.
VACCINE (2018)
Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine
Emma E. Seagle et al.
VACCINE (2018)
Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada
Arnaud G. L'Huillier et al.
VIROLOGY JOURNAL (2018)
The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?
Brian J. Ward et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China
Aili Cui et al.
VACCINE (2018)
Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany
Andrea-Ioana Beleni et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Mumps Outbreaks at Four Universities - Indiana, 2016
Mugdha Golwalkar et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
A framework for research on vaccine effectiveness
Natasha S. Crowcroft et al.
VACCINE (2018)
Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations
Silvia Sanchez-Ramon et al.
FRONTIERS IN IMMUNOLOGY (2018)
Vaccination Coverage Among Children Aged 19-35 Months - United States, 2017
Holly A. Hill et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Vaccination Coverage for Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2017-18 School Year
Jenelle L. Mellerson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Importation of Mumps Virus Genotype K to China from Vietnam
Wei Liu et al.
EMERGING INFECTIOUS DISEASES (2018)
Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016
Minesh Shah et al.
CLINICAL INFECTIOUS DISEASES (2018)
Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population
L. A. Trotz-Williams et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Increasing mumps incidence rates among children and adolescents in the Republic of Korea: age-period-cohort analysis
Young-June Choe et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control
Cristina V. Cardemil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cellular and humoral immunity after vaccination or natural mumps infection
Kihei Terada et al.
PEDIATRICS INTERNATIONAL (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Reemergence of mumps in Sao Paulo, Brazil - the urgent need for booster shot campaign to prevent a serious infectious disease
Paulo Roberto Urbano et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2017)
Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China
James Zengel et al.
VACCINE (2017)
Absence of Asymptomatic Mumps Virus Shedding Among Vaccinated College Students During a Mumps Outbreak - Washington, February-June 2017
Jesse Bonwitt et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015
Aili Cui et al.
PLOS ONE (2017)
Misinformation lingers in memory: Failure of three pro-vaccination strategies
Sara Pluviano et al.
PLOS ONE (2017)
Complete Genome Sequence of the WHO International Standard for Hepatitis B Virus DNA
Adrian Jenkins et al.
GENOME ANNOUNCEMENTS (2017)
Systematic Review of Measles and Rubella Serology Studies
Kimberly M. Thompson et al.
RISK ANALYSIS (2016)
Detection of mumps virus genotype H in two previously vaccinated patients from Mexico City
Alberto del Valle et al.
ARCHIVES OF VIROLOGY (2016)
Waning immunity against mumps in vaccinated young adults, France 2013
S. Vygen et al.
EUROSURVEILLANCE (2016)
Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes
Sunil R. Vaidya et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus
Lena Kenny et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen
Brenna C. Simons et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose
Michael G. Bruce et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Genetic Characteristics of Mumps Viruses Isolated in Korea From 2007 to 2012
Seung Tae Kim et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain
Donald D. Raymond et al.
NATURE MEDICINE (2016)
Emerging Mumps Infection
Steven Rubin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Severity of mumps disease is related to MMR vaccination status and viral shedding
Sigrid Gouma et al.
VACCINE (2016)
Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection
Sigrid Gouma et al.
VACCINE (2016)
Vaccinology in the third millennium: scientific and social challenges
Gregory A. Poland et al.
CURRENT OPINION IN VIROLOGY (2016)
How to determine protective immunity in the post-vaccine era
Carmen L. Charlton et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Primary vaccine failure to routine vaccines: Why and what to do?
Ursula Wiedermann et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Laboratory Diagnosis of Mumps in a Partially Immunized Population: The Nova Scotia Experience
TF Hatchette et al.
Canadian Journal of Infectious Diseases & Medical Microbiology (2016)
Discovering protective CD8 T cell epitopes - no single immunologic property predicts it!
Pavlo Gilchuk et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes
Christopher C. Stobart et al.
EXPERT REVIEW OF VACCINES (2015)
Laboratory-based investigation of suspected mumps cases submitted to the German National Reference Centre for Measles, Mumps, and Rubella, 2008 to 2013
Annette Mankertz et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Mumps outbreak and laboratory diagnosis
Mylene Maillet et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Identification of conformational neutralization sites on the fusion protein of mumps virus
Maja Santak et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Proteomic contributions to our understanding of vaccine and immune responses
Allison C. Galassie et al.
PROTEOMICS CLINICAL APPLICATIONS (2015)
Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers
Kihei Terada et al.
VACCINE (2015)
Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial
Sanjay Lalwani et al.
BMJ OPEN (2015)
Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases
C. Stein Zamir et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic
Patricia Kaaijk et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Missed Opportunities for Measles, Mumps, and Rubella (MMR) Immunization in Mesoamerica: Potential Impact on Coverage and Days at Risk
Ali H. Mokdad et al.
PLOS ONE (2015)
Genomic diversity of mumps virus and global distribution of the 12 genotypes
Li Jin et al.
REVIEWS IN MEDICAL VIROLOGY (2015)
Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months
Maurice A. Mufson et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2015)
Estimates of Mumps Seroprevalence May Be Influenced by Antibody Specificity and Serologic Method
Donald R. Latner et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Vaccines for the 21st century
Isabel Delany et al.
EMBO MOLECULAR MEDICINE (2014)
Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study
S. Borgmann et al.
EPIDEMIOLOGY AND INFECTION (2014)
Challenges in mucosal vaccines for the control of infectious diseases
Tatsuhiko Azegami et al.
INTERNATIONAL IMMUNOLOGY (2014)
Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012)
Sigrid Gouma et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Immunogenicity of Novel Mumps Vaccine Candidates Generated by Genetic Modification
Pei Xu et al.
JOURNAL OF VIROLOGY (2014)
Highly parallel characterization of IgG Fc binding interactions
Austin W. Boesch et al.
MABS (2014)
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
Shuzhao Li et al.
NATURE IMMUNOLOGY (2014)
Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
Eliane Matos dos Santos et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2014)
Effective Messages in Vaccine Promotion: A Randomized Trial
Brendan Nyhan et al.
PEDIATRICS (2014)
Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children
Hanging He et al.
VACCINE (2014)
Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? An immunoinformatic analysis
E. Jane Homan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009-2012
Jussi Sane et al.
EMERGING INFECTIOUS DISEASES (2014)
Comparison of the Sensitivity of Laboratory Diagnostic Methods from a Well-Characterized Outbreak of Mumps in New York City in 2009
Jennifer S. Rota et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies
M. Santak et al.
EPIDEMIOLOGY AND INFECTION (2013)
Epidemiology of a Mumps Outbreak in a Highly Vaccinated Island Population and Use of a Third Dose of Measles-Mumps-Rubella Vaccine for Outbreak Control-Guam 2009 to 2010
George E. Nelson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks
Gaby Smits et al.
PLOS ONE (2013)
Measles, mumps and rubella (MMR) vaccination has no effect on cognitive development in children - The results of the Polish prospective cohort study
Dorota Mrozek-Budzyn et al.
VACCINE (2013)
Delaying Vaccination Is Not a Safer Choice
Kristen A. Feemster et al.
JAMA PEDIATRICS (2013)
A Population-Based Cohort Study of Undervaccination in 8 Managed Care Organizations Across the United States
Jason M. Glanz et al.
JAMA PEDIATRICS (2013)
Measles Elimination Efforts and 2008-2011 Outbreak, France
Denise Antona et al.
EMERGING INFECTIOUS DISEASES (2013)
Aerosolized MMR vaccine: Evaluating potential transmission of components to vaccine administrators and contacts of vaccinees
Jose-Luis Diaz-Ortega et al.
BIOLOGICALS (2012)
Vaccines against mucosal infections
Jan Holmgren et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children
Markus Knuf et al.
EUROPEAN JOURNAL OF PEDIATRICS (2012)
Seroepidemiology of the recent mumps virus outbreaks in Ireland
Jaythoon Hassan et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Recent Mumps Outbreaks in Vaccinated Populations: No Evidence of Immune Escape
Steven A. Rubin et al.
JOURNAL OF VIROLOGY (2012)
200TH ANNIVERSARY ARTICLE The Burden of Disease and the Changing Task of Medicine
David S. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for Seronegativity
Christina Poethko-Mueller et al.
PLOS ONE (2012)
Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development
Inna G. Ovsyannikova et al.
AAPS JOURNAL (2011)
Enzyme-Linked Immunospot Assay Detection of Mumps-Specific Antibody-Secreting B Cells as an Alternative Method of Laboratory Diagnosis
Donald R. Latner et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Live Attenuated Influenza Vaccine (FluMist (R); Fluenz (TM)) A Review of its Use in the Prevention of Seasonal Influenza in Children and Adults
Natalie J. Carter et al.
DRUGS (2011)
Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?
R. Allwinn et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine
Paolo Durando et al.
HUMAN VACCINES (2011)
Progress Toward Measles Elimination in the Russian Federation, 2003-2009
G. Onishchenko et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Mumps Antibody Levels Among Students Before a Mumps Outbreak: In Search of a Correlate of Immunity
Margaret M. Cortese et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Proteomics for development of vaccine
Monika Adamczyk-Poplawska et al.
JOURNAL OF PROTEOMICS (2011)
Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries
Larisa Rudenko et al.
VACCINE (2011)
Transmission of mumps virus from mumps-vaccinated individuals to close contacts
Ewout B. Fanoy et al.
VACCINE (2011)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Guidance for Isolation Precautions for Mumps in the United States: A Review of the Scientific Basis for Policy Change
Preeta K. Kutty et al.
CLINICAL INFECTIOUS DISEASES (2010)
Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice
Corinne Vandermeulen et al.
IMMUNOLOGY (2010)
Molecular Epidemiological Evaluation of the Recent Resurgence in Mumps Virus Infections in Ireland
Michael J. Carr et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Evaluation of the Persistence of Vaccine-Induced Protection with Human Vaccines
E. Vidor
JOURNAL OF COMPARATIVE PATHOLOGY (2010)
Mumps Outbreak in the Republic of Moldova, 2007-2008
Norbert G. Schwarz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004
Heinrich J. Brockhoff et al.
VACCINE (2010)
Genotyping of mumps virus circulating in Turkey in the 2006-2007 winter season
Alper Akcali et al.
ARCHIVES OF VIROLOGY (2009)
Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2
Phil Chambers et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Evaluation of Cellular Immunity to Mumps in Vaccinated Individuals with or without Circulating Antibodies up to 16 Years after Their Last Vaccination
Corinne Vandermeulen et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Persistence of Mumps Antibodies after 2 Doses of Measles-Mumps-Rubella Vaccine
Charles W. LeBaron et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Investigation of a Mumps Outbreak Among University Students With Two Measles-Mumps-Rubella (MMR) Vaccinations, Virginia, September-December 2006
J. S. Rota et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra™): Immunogenicity and safety profile
Czajka Hanna et al.
VACCINE (2009)
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine
Y. Gillet et al.
VACCINE (2009)
Mumps resurgences in the United States: A historical perspective on unexpected elements
Albert E. Barskey et al.
VACCINE (2009)
The duration of mumps virus shedding after the onset of symptoms
Philip M. Polgreen et al.
CLINICAL INFECTIOUS DISEASES (2008)
Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?
Gustavo H. Dayan et al.
CLINICAL INFECTIOUS DISEASES (2008)
Mumps vaccine performance among university students during a mumps outbreak
Margaret M. Cortese et al.
CLINICAL INFECTIOUS DISEASES (2008)
Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage
Rebecca H. Bitsko et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Immune responses to mumps vaccine in adults who were vaccinated in childhood
Rima Hanna-Wakim et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up
Irja Davidkin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a University population
Anand A. Date et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak
Steven A. Rubin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Primary vaccine failure after 1 dose of varicella vaccine in healthy children
David E. Michalik et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme
Heikki Peltola et al.
LANCET INFECTIOUS DISEASES (2008)
Recent resurgence of mumps in the United States
Gustavo H. Dayan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006
Mona Marin et al.
VACCINE (2008)
Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of Sao Paulo, Brazil
C. L. S. Santos et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination
Sari Jokinen et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines
Heikki Peltola et al.
CLINICAL INFECTIOUS DISEASES (2007)
Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004
A. V. Atrasheuskaya et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003
Alena V. Atrasheuskaya et al.
VACCINE (2007)
Mumps outbreak in a highly vaccinated school population: Assessment of secondary vaccine failure using IgG avidity measurements
Dae Won Park et al.
VACCINE (2007)
Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom
E. Miller et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains
S Rubin et al.
VACCINE (2006)
Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus
AV Atrasheuskaya et al.
VACCINE (2006)
Function of small hydrophobic proteins of paramyxovirus
RL Wilson et al.
JOURNAL OF VIROLOGY (2006)
Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications
GP Pijlman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination
N Dhiman et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population
G Ong et al.
JOURNAL OF INFECTION (2005)
Mumps virus-specific antibody titers from pre-vaccine era sera: Comparison of the plaque reduction neutralization assay and enzyme immunoassays
J Mauldin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Measles in Saudi Arabia: from control to elimination
MKM Khalil et al.
ANNALS OF SAUDI MEDICINE (2005)
The effectiveness of the mumps component of the MMR vaccine: a case control study
R Harling et al.
VACCINE (2005)
Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay
JAC Schalk et al.
BIOLOGICALS (2005)
Contrasting B cell- and T cell-based protective vaccines
VAA Jansen et al.
JOURNAL OF THEORETICAL BIOLOGY (2005)
Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children
N Dhiman et al.
CLINICAL IMMUNOLOGY (2005)
Molecular identification of mumps virus genotypes from clinical samples: Standardized method of analysis
G Palacios et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
Identifying epitopes of HIV-1 that induce protective antibodies
S Zolla-Pazner
NATURE REVIEWS IMMUNOLOGY (2004)
The molecular epidemiology of mumps virus
Kathrin Muehlemann
INFECTION GENETICS AND EVOLUTION (2004)
Outbreak of mumps in a vaccinated child population: a question of vaccine failure?
C Vandermeulen et al.
VACCINE (2004)
Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000
S Utz et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Measles in Mexico, 1941-2001: Interruption of endemic transmission and lessons learned
JI Santos et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Progress toward measles elimination in Germany
W Hellengbrand et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Measles, mumps, rubella vaccine (Priorix (TM); GSK-MMR) - A review of its use in the prevention of measles, mumps and rubella
K Wellington et al.
DRUGS (2003)
Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia
Y Al-Mazrou et al.
JOURNAL OF TROPICAL PEDIATRICS (2002)
Sequence diversity of Jeryl Lynn strain of mumps virus: Quantitative mutant analysis for vaccine quality control
G Amexis et al.
VIROLOGY (2002)
Proposed criteria for classification of new genotypes of mumps virus
B Johansson et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain
SS da Cunha et al.
VACCINE (2002)
Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes
R Nanan et al.
VACCINE (2001)
Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months
H Gans et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype
J Nöjd et al.
VACCINE (2001)
The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella
N Andrews et al.
EPIDEMIOLOGY AND INFECTION (2000)
Measles resurgence in Argentina: 1997-8 outbreak
MD Bilkis et al.
EPIDEMIOLOGY AND INFECTION (2000)
Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination
N Bautista-López et al.
VACCINE (2000)
Share Paper
